Indications for and long-term survival in patients with automatic implantable cardioverter-defibrillators.

Abstract:

:Automatic implantable cardioverter-defibrillators (AICDs) were implanted in 378 men and 95 women, mean age 69 +/- 12 years. At 3.6-year follow up, survival was 76% in patients who had an AICD because of cardiac arrest as a result of ventricular fibrillation or ventricular tachycardia not resulting from a transient or reversible cause; 85% in patients who had an AICD because of spontaneous sustained ventricular tachycardia in association with structural heart disease; 92% in patients who had an AICD because of syncope of undetermined origin with clinically relevant, hemodynamically sustained ventricular tachycardia or ventricular fibrillation induced at electrophysiological study when drug therapy is ineffective, not tolerated, or not preferred; 84% in patients who had an AICD because of nonsustained ventricular tachycardia with coronary artery disease, prior myocardial infarction, left ventricular dysfunction, and inducible ventricular fibrillation or sustained ventricular tachycardia at electrophysiological study that is not suppressible by a class I antiarrhythmic drug; and 85% in all 473 patients who had an AICD.

journal_name

Cardiol Rev

journal_title

Cardiology in review

authors

Aronow WS,Sorbera C,Chagarlamudi A,Tabandeh H,Gupta S,Cohen M

doi

10.1097/01.crd.0000128728.49766.3f

keywords:

subject

Has Abstract

pub_date

2005-01-01 00:00:00

pages

50-1

issue

1

eissn

1061-5377

issn

1538-4683

pii

01.crd.0000128728.49766.3f

journal_volume

13

pub_type

杂志文章
  • Evaluation of the Emergency Department chest pain patient.

    abstract::Patients presenting to the Emergency Department with chest pain are common and often present diagnostic difficulties. Because of the limitations of the initial evaluation, the majority of patients are admitted, although many are later found to have noncardiac causes for their symptoms. Recognition of these limitations...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200109000-00006

    authors: Kontos MC

    更新日期:2001-09-01 00:00:00

  • Role of Antiplatelet Therapy and Anticoagulation in Nonischemic Cardiomyopathy.

    abstract::Heart failure continues to be a leading cause of morbidity and mortality throughout the United States. The pathophysiology of heart failure involves the activation of complex neurohormonal pathways, many of which mediate not only hypertrophy and fibrosis within ventricular myocardium and interstitium, but also activat...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000094

    authors: Carazo M,Berger JS,Reyentovich A,Katz SD

    更新日期:2016-09-01 00:00:00

  • Cardiac Resynchronization Therapy: Maximizing the Response to Biventricular Pacing.

    abstract::Cardiac resynchronization therapy (CRT) has become a mainstay therapy to improve clinical outcomes of patients with left ventricular systolic dysfunction and a wide QRS complex, in addition to guideline-directed medical therapy. As clinical experience with CRT continues to expand, the device and lead design, along wit...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000127

    authors: Ng CY,Heist EK

    更新日期:2017-01-01 00:00:00

  • Ambulatory electrocardiology.

    abstract::About 50 years ago, Norman Jefferis Holter invented a device that opened the possibility of recording heart activity over long periods of time. This invention, together with the rapid developments in electronics, has enabled a revolutionary change in the diagnosis and management of cardiac diseases. Ambulatory cardiac...

    journal_title:Cardiology in review

    pub_type: 历史文章,杂志文章,评审

    doi:10.1097/CRD.0b013e31828a8294

    authors: Romero I

    更新日期:2013-09-01 00:00:00

  • Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events.

    abstract::Antiplatelet therapy reduces the risks for cardiovascular morbidity and mortality in patients with atherosclerotic disease, and it is also beneficial in managing peripheral arterial disease (PAD). These agents work through various therapeutic pathways to achieve antithrombotic effects. Although single- or two-drug reg...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000075

    authors: Lam S,Tran T

    更新日期:2015-09-01 00:00:00

  • Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

    abstract::Cholesterol metabolism and transport has been a major focus in cardiovascular disease risk modification over the past several decades. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) have been the most commonly used agents, with the greatest benefit in reducing both the primary and secondary risks of cardiova...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000245

    authors: Grabie M,Tai CH,Frishman WH

    更新日期:2019-09-01 00:00:00

  • Lipid-altering therapy and atrial fibrillation.

    abstract::Atrial fibrillation (AF) is a common cardiac arrhythmia with significant morbidity and public health cost. Because of limitations of efficacy and safety of conventional antiarrhythmic agents, alternative therapies for AF are needed. The potential antiarrhythmic properties of lipid-altering therapy, including the 3-hyd...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e318177271d

    authors: Bachmann JM,Majmudar M,Tompkins C,Blumenthal RS,Marine JE

    更新日期:2008-07-01 00:00:00

  • Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures.

    abstract::As direct oral anticoagulants (DOACs) have demonstrated favorable efficacy and safety outcomes compared with vitamin K antagonists for the treatment and prevention of venous thromboembolism and the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, their role in the management...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000188

    authors: Finks SW,Dobesh PP,Trujillo TC,Crossley GH

    更新日期:2018-09-01 00:00:00

  • Perspectives on sudden death prevention in hypertrophic cardiomyopathy.

    abstract::Sudden death (SD) is the most dramatic event in hypertrophic cardiomyopathy (HCM), often representing the first clinical manifestation of the disease, and the first concern of the clinicians who take care of such patients. HCM is now recognized as the primary cause of SD in young persons (<35 years of age), including ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000017

    authors: Efthimiadis GK,Zegkos T,Meditskou S,Hadjimiltiades S

    更新日期:2014-09-01 00:00:00

  • Chest pain from gastroesophageal reflux disease in patients with coronary artery disease.

    abstract::Management of patients with coronary artery disease is a major challenge for physicians, patients, and the healthcare system. Chest pain experienced by patients with coronary disease can be of noncardiac origin, and symptoms frequently related to gastroesophageal etiologies. The distal esophagus and the heart share a ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000148844.13702.ce

    authors: Liuzzo JP,Ambrose JA

    更新日期:2005-07-01 00:00:00

  • Recent advances in echocardiographic evaluation of left ventricular anatomy, perfusion, and function.

    abstract::This article provides a brief overview of several recently developed, emerging technologies and discusses their potential uses on clinical grounds. These new technologies include three-dimensional imaging, objective automated evaluation of ventricular function with acoustic quantification, assessment of regional ventr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200105000-00008

    authors: Mor-Avi V,Lang RM

    更新日期:2001-05-01 00:00:00

  • Women do benefit from lipid lowering: latest clinical trial data.

    abstract::Cardiovascular disease is the leading cause of morbidity and mortality among women in industrialized nations. Optimizing cardiovascular risk reduction is therefore of paramount importance, particularly among postmenopausal women, in whom the incidence of cardiovascular disease is highest. Accumulated data from a serie...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200301000-00003

    authors: Mostaghel E,Waters D

    更新日期:2003-01-01 00:00:00

  • A Review of Remdesivir for COVID-19: Data to Date.

    abstract::Severe acute respiratory coronavirus-2 (SARS-CoV-2) is responsible for one of the greatest public health challenges of our lifetime, the coronavirus disease 2019 (COVID-19) pandemic. Because of the complicated postinfection sequelae and grave consequences, the search for effective therapies has become a worldwide prio...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000337

    authors: Mehta M,Shyh GI

    更新日期:2020-11-01 00:00:00

  • Mitral valve endocarditis resulting from coagulase-negative Staphylococcus after stent implantation in a saphenous vein graft.

    abstract::Valvular endocarditis after percutaneous coronary intervention is unusual. We report a new case of mitral valve endocarditis after stent implantation to a saphenous vein graft. ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000128842.48947.21

    authors: Palmer ND,Ramsdale DR

    更新日期:2005-05-01 00:00:00

  • Short QT Syndrome in Current Clinical Practice.

    abstract::Short QT syndrome is a rare inherited autosomal dominant cardiac channelopathy associated with malignant ventricular and atrial arrhythmias. A shortened corrected QT interval is a marker for risk of malignant arrhythmias, which are secondary to increased transmural dispersion of repolarization. The underlying gain of ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000091

    authors: Khera S,Jacobson JT

    更新日期:2016-07-01 00:00:00

  • Endothelin as a clinical target in the treatment of systemic hypertension.

    abstract::Endothelin is a potent vasoconstrictor substance that also can exert proliferative, inflammatory, and fibrotic changes in blood vessels and other organs. It acts on tissues in a paracrine and autocrine fashion, with local production and regulation occurring in both endothelial and nonendothelial cells. Endothelin stim...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181aa8f4a

    authors: Prasad VS,Palaniswamy C,Frishman WH

    更新日期:2009-07-01 00:00:00

  • Ayurveda and Yoga in Cardiovascular Diseases.

    abstract::Ayurveda is derived from 2 Sanskrit words, namely, "Ayus" and "Veda," meaning life and knowledge, respectively. It literally means science of life. Ayurveda, of which yoga is an integral part, is widely practiced in India and is gaining acceptance in many countries around the world. It is a comprehensive and a holisti...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000128730.31658.36

    authors: Mamtani R,Mamtani R

    更新日期:2004-09-01 00:00:00

  • The Sexual Dimorphism of High Blood Pressure.

    abstract::There is a sexual dimorphism in blood pressure: men tend to have higher blood pressures than women with functional ovaries, whereas ovariectomy or menopause tends to abolish the sexual dimorphism and cause women to develop a "male" pattern of blood pressure. Synthetic estrogens and progestins, found in oral contracept...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-199811000-00012

    authors: Calhoun DA,Oparil S

    更新日期:1998-11-01 00:00:00

  • Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation.

    abstract::Atrial fibrillation (AF) is an independent risk factor for ischemic stroke occurrence, severity, recurrence, and mortality. Anticoagulation therapy for the prevention of thromboembolism is critical in patients with AF who are at risk of stroke. Warfarin has been an efficacious anticoagulant for this purpose, but its u...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0b013e318293d6e6

    authors: Lam S

    更新日期:2013-07-01 00:00:00

  • Diagnosis and management of renovascular hypertension.

    abstract::Renovascular hypertension caused by renal artery stenosis accounts for a small portion of overall hypertension but remains important as the most common potentially curable form of high blood pressure. Diagnosis depends on developing an index of suspicion for renovascular hypertension based on the history and physical ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008010-00005

    authors: Klassen PS,Svetkey LP

    更新日期:2000-01-01 00:00:00

  • Pulmonary arterial hypertension and women.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disorder with a poor prognosis. It is characterized by sustained elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). It is defined hemodynamically by a mean PAP over 25 mm Hg, a pulmonary arterial wedge pressure of 15 mm Hg or les...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000240529.49704.2e

    authors: De Marco T

    更新日期:2006-11-01 00:00:00

  • Left Ventricular Noncompaction: Diagnostic Approach, Prognostic Evaluation, and Management Strategies.

    abstract::Left ventricular noncompaction cardiomyopathy is a heart disease with relevant potential complications including heart failure, life-threatening arrhythmias, and embolic events. In order to prevent adverse outcomes, it is crucial to appropriately recognize and manage this cardiomyopathy. In this paper, we report the m...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000251

    authors: Di Fusco SA,Lucà F,Madeo A,Massimiliano Rao C,Iorio A,Rizzo M,Dalila Luisella Delcre S,Colivicchi F,Gabrielli D,Paolo Pino G,Massimo Gulizia M

    更新日期:2020-05-01 00:00:00

  • Epigenetic regulation in heart failure: part II DNA and chromatin.

    abstract::Epigenetic regulatory mechanisms play key roles in cardiac development, differentiation, homeostasis, response to stress and injury, and disease. Human heart failure (HF) epigenetic regulatory mechanisms have not been deciphered to date. This 2-part review distills the rapidly evolving research focused on human HF epi...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000074

    authors: DiSalvo TG

    更新日期:2015-11-01 00:00:00

  • Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.

    abstract::The effect of an ongoing educational program on the use of cardiovascular drugs in patients with coronary artery disease without contraindications to these drugs seen in an academic cardiology clinic was assessed in 100 patients seen during the 6-month period prior to the educational program and in 200 patients seen 9...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000131191.57664.e7

    authors: Nayak D,Aronow WS

    更新日期:2005-03-01 00:00:00

  • A novel approach to left atrial appendage exclusion: the WATCHMAN device.

    abstract::Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181e53abb

    authors: Gorodnitskiy A,Lucariello RJ,Aizer A,Coppola JT

    更新日期:2010-09-01 00:00:00

  • The Mediterranean Diet and Cardiovascular Disease: Gaps in the Evidence and Research Challenges.

    abstract::In this article, we critically evaluate the evidence relating to the effects of the Mediterranean diet (MD) on the risk of cardiovascular disease (CVD). Strong evidence indicating that the MD prevents CVD has come from prospective cohort studies. However, there is only weak supporting evidence from randomized controll...

    journal_title:Cardiology in review

    pub_type: 杂志文章,meta分析,评审

    doi:10.1097/CRD.0000000000000222

    authors: Temple NJ,Guercio V,Tavani A

    更新日期:2019-05-01 00:00:00

  • Cardiac allograft vasculopathy: advances in diagnosis.

    abstract::Cardiac allograft vasculopathy (CAV), characterized by diffuse intimal thickening and luminal narrowing in the arteries of the allograft, is the leading cause of morbidity and mortality in cardiac transplant recipients. Many transplant centers perform routine annual surveillance coronary angiography. However, angiogra...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181fbde2f

    authors: Cai Q,Rangasetty UC,Barbagelata A,Fujise K,Koerner MM

    更新日期:2011-01-01 00:00:00

  • Pacemakers and store security devices.

    abstract::The ever-increasing complexity of medical device therapy and installation of public electronic security systems demands vigilance in discerning interactions that may be harmful to patients during typical activities of daily living. Premature pacemaker stimulation, isolated skipped beats, or reversion to backup asynchr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200101000-00004

    authors: Harthorne JW

    更新日期:2001-01-01 00:00:00

  • Antiretroviral and statin drug-drug interactions.

    abstract::Patients living with the human immunodeficiency virus (HIV) are at risk for dyslipidemia as a result of the disease itself and from certain classes of antiretroviral therapy. The protease inhibitors and non-nucleoside reverse transcription inhibitors have been associated with elevated triglycerides, total, and low-den...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181903b7f

    authors: Ray GM

    更新日期:2009-01-01 00:00:00

  • Antithrombotic therapy in patients with heart valve prostheses.

    abstract::Heart valve prostheses carry a risk for thrombosis and require an antithrombotic strategy to prevent stroke, systemic embolism, and prosthetic valve thrombosis. Contemporary randomized trials to guide the clinician on the optimal anticoagulant treatment are scarce, and the validity of the historical data for current r...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182638578

    authors: Hermans H,Vanassche T,Herijgers P,Meuris B,Herregods MC,Van de Werf F,Verhamme P

    更新日期:2013-01-01 00:00:00